Modified body adiposity index for body fat estimation in severe obesity
Carregando...
Citações na Scopus
16
Tipo de produção
article
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Citação
JOURNAL OF HUMAN NUTRITION AND DIETETICS, v.30, n.2, p.177-184, 2017
Resumo
BackgroundThe body adiposity index (BAI) comprises a simple method for estimating body fat (BF) that needs to be validated in patients with severe obesity. The present study aimed to determine BAI accuracy with respect to the determination BF in patients with severe obesity. MethodsA cross-sectional prospective study comparing two methods for BF estimation was conducted in 433 patients with severe obesity between August 2012 to December 2014. BF was estimated by bioelectrical impedance analysis (BIA) with specific equations developed for BF estimation in patients with severe obesity and BAI. The BF estimation in 240 patients with severe obesity (Group 1: G1) was used to evaluate BAI limitations and to develop a specific equationin this population. The new equationproposed was validated in another 158 patients with severe obesity (Group 2: G2). ResultsThere was a significant difference between BF determination by BIA and BAI (P=0.039). The mean (SD) BF in G1 was 52.3%(6.1%) determined by BIA and 51.6%(8.1%) determined by BAI. Sex, waist-hip ratio (WHR) and obesity grade determined significant errors on BF estimation by BAI. A new equation(modified body adiposity index; MBAI) was developed by linear regression to minimise these errors [MBAI%=23.6+0.5x(BAI); add 2.2 if body mass index50kgm(-2) and 2.4 if WHR1.05]. The new equationreduced the difference [1.2% (5.9%), P<0.001 to 0.4%(4.12%), P=0.315] and improved the correlation (0.6-0.7) between methods. ConclusionsBAI present significant limitations in severe obesity and MBAI was effective for BF estimation in this population.
Palavras-chave
bioelectrical impedance analysis, body adiposity index, body composition, severe obesity, waist-hip ratio
Referências
- Berentzen T, 2006, NUTR REV, V64, P502, DOI [10.1301/nr.2006.nov.502-507, 10.1301/nr.2006.nov.502507]
- Bergman RN, 2011, OBESITY, V19, P1083, DOI 10.1038/oby.2011.38
- Braulio VB, 2010, ARQ BRAS ENDOCRINOL, V54, P398, DOI 10.1590/S0004-27302010000400009
- Cerqueira M, 2013, OBESITY, V21, pE696, DOI 10.1002/oby.20543
- Das SK, 2005, CURR OPIN CLIN NUTR, V8, P602, DOI 10.1097/01.mco.0000171122.60665.5f
- Das SK, 2003, AM J PHYSIOL-ENDOC M, V6, P1080
- Deurenberg P, 1996, AM J CLIN NUTR, V64, P449
- Elisha B, 2013, EUR J NUTR, V52, P145, DOI 10.1007/s00394-011-0296-y
- Geliebter A., 2013, OBESITY, V21, P1, DOI [10.1002/oby.20264.Comparison, DOI 10.1002/OBY.20264.COMPARISON]
- Gibson C D, 2012, Int J Body Compos Res, V10, P9
- GRAY DS, 1989, AM J CLIN NUTR, V50, P255
- Gupta S, 2014, ISRN OBES, V2014
- Heath EM, 1998, J AM DIET ASSOC, V98, P869, DOI 10.1016/S0002-8223(98)00201-6
- Hensrud DD, 2006, MAYO CLIN PROC, V81, pS5
- Horie LM, 2008, CLIN NUTR, V27, P350, DOI 10.1016/j.clnu.2008.03.011
- Jimenez A, 2012, OBES SURG, V22, P587, DOI 10.1007/s11695-011-0570-3
- Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012
- Lam BCC, 2013, OBESITY, V21, pE634, DOI 10.1002/oby.20504
- Lausen B, 1994, CONTR STAT, P483
- Lemacks JL, 2012, MENOPAUSE, V19, P1277, DOI 10.1097/gme.0b013e31825408e5
- Mathieu Patrick, 2008, Can J Cardiol, V24 Suppl D, p19D
- Muller MJ, 2012, OBES REV, V13, P6, DOI 10.1111/j.1467-789X.2012.01033.x
- O'Brien C, 2002, INT J SPORTS MED, V23, P361, DOI 10.1055/s-2002-33145
- Ogden Cynthia L, 2013, NCHS Data Brief, P1
- Sartorio A, 2005, EUR J CLIN NUTR, V59, P155, DOI 10.1038/sj.ejcn.1602049
- Scicchitano P, 2014, J FUNCT FOODS, V6, P11, DOI 10.1016/j.jff.2013.12.006
- Shah NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033308
- SHEPHARD RJ, 1988, J APPL PHYSIOL, V64, P1472
- Silva AM, 2004, AM J PHYSIOL-ENDOC M, V287, pE962, DOI 10.1152/ajpendo.00104.2004
- Thomson R, 2007, CLIN NUTR, V26, P771, DOI 10.1016/j.clnu.2007.08.003
- World Health Organization, 2000, WHO TECH REP SER, V25, P3